A Validated Chiral HPLC Method for the Enantiomeric Separation of Melphalan HCl

Article Preview

Abstract:

A new and accurate chiral HPLC method was developed for the determination of Melphalan HCl, L-Phenylalanine, 4-bis (2-chloroethyl) amino hydrochloride an anti-cancer chemotherapy drug and its potential impurity namely D-Phenylalanine, 4-bis (2-chloroethyl) amino hydrochloride ( D-enantiomer) in bulk substance. HPLC separation was carried out by reverse phase chromatography on Crownpak CR (+) (5μm, 4.0x150mm) with a mobile phase composed of perchloric acid (pH 4.0): methanol in the ratio of 90:10. Melphalan and its potential impurities were baseline resolved in the optimized method. The pH of perchloric acid solution in the mobile phase has played a key role in achieving chromatographic resolution between the enantiomers and in enhancing chromatographic efficiency. The developed method was completely validated and proved to be robust. The validated method yielded good results regarding specificity, precision, linearity, accuracy, robustness, sensitivity. Melphalan HCl sample solution is found to be stable for at least 60hrs at room temperature. The proposed method was found to be suitable and accurate for quantitative determination of Melphalan HCl and its D-enantiomer in bulk substance.

You might also be interested in these eBooks

Info:

Periodical:

Advanced Materials Research (Volumes 781-784)

Pages:

993-998

Citation:

Online since:

September 2013

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2013 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] G.J. Ossenkoppele, G.J. Schuurhuis, A.R. Jonkhoff, K.G. van der Hem, M.C.J.C. Legdeur, A. Boot-Bakker, A.H. Westra, A.M. Dräger, P.C. Huijgens. European Journal of Cancer, 32(12), 1996, 2058-(2063).

DOI: 10.1016/s0959-8049(96)00267-5

Google Scholar

[2] Krzysztof Bielawski, Anna Bielawska, KatarzynaSosnowska, WojciechMiltyk, KatarzynaWinnicka, Jerzy Pałka. Biochemical Pharmacology, 72(3), 2006, 320-331.

Google Scholar

[3] K. Brightman, G. Finlay, I. Jarvis, T. Knowlton, C.T. Manktelow. Journal of Pharmaceutical and Biomedical Analysis, 20(3), 1999, 439-447.

DOI: 10.1016/s0731-7085(99)00011-4

Google Scholar